Centum Electronics Ltd Q1 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/ucj4zmt3cj7x3d1gpmedgkx9.pdf

Key Takeaways


The UAE Contract & Accounting Distortion

Nikhil Mallavarapu: "The auditors have asked us to account it on a net basis rather than a gross basis. For the quarter, as mentioned, the impact from the top line only was to the tune of about INR23 crores."

Margin Bridge & Recovery Path

Nikhil Mallavarapu: "We expect the majority of it to happen in H2. As I mentioned, there are two factors. One is the BTS defense business where we are expecting almost 70% of our invoicing to happen in the second half of the year."

Segment Dynamics

SegmentTrendCommentary
BTS (Build-to-Spec)▼ Soft Q1, ▲ H2 recoveryDomestic defense and space orders skewed to H2; operates in high-end areas (radar, electronic warfare) where the Make in India pie is expanding.
EMS (Electronics Manufacturing)▲ Growth driverRoughly half is defense/aerospace (missiles, radios, air traffic management); industrial includes grid and industrial automation; transport covers railways and EV components for heavy vehicles; healthcare includes digital radiography. Recurring in nature with quarterly fluctuation.
Engineering Services▬ Shifting modelReducing exposure to high-risk fixed-price contracts, moving toward shorter-horizon service and consulting engagements.
Subsidiary (France)▲ ImprovingRestructuring drove margin from negative to 3%; Q2 seasonally slower, Q3 and Q4 stronger; target growth is high single digit to ~10%.
K.S. Desikan: "The BTS business, the domestic defense space et cetra, I think the opportunity is exploding in terms of Make in India or the positive indigenization list. The pie is only increasing and we choose to operate at a certain high end of the technology areas like the radar, electronic warfare, et cetera."

Order Book & Pipeline


Risks & Watchpoints

Nikhil Mallavarapu: "One area of risk which we continue to monitor closely is around the delivery of their PCB boards from our supply base in France, which is specific to one of our large customers in the segment. Having said that, we are taking various mitigating actions to address that well in advance."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth (gross basis)18%-20%FY25
Net accounting drag on top line5%-6% reductionFY25
Standalone EBITDA margin13%+FY25 full-year
Consolidated EBITDA margin10%-11% (excluding other income)FY25 full-year
Working capital daysReturn to ~61 daysEnd of September
Net debtReduce to ~INR180 crEnd of September
Net debtReduce to ~INR170 crYear-end
Interest costINR35-40 crFY25
Standalone growth rate25%+Medium-term target
Subsidiary growth rateHigh single digit to ~10%Medium-term target
Consolidated EBITDA margin13%-15%Medium-term target
North American ordersSecured from customers in qualificationBy year-end

Key Metrics

MetricQ1 FY25
Revenue from operations (consolidated)₹246 cr, flat YoY
Adjusted revenue (gross basis)₹264.5 cr, +7% YoY adjusted for net accounting of a contract
EBITDA (consolidated)₹16 cr, down YoY
EBITDA margin (consolidated)6.34%, down YoY
Standalone EBITDA margin target (full year)~13%+
Consolidated EBITDA margin target (full year)10% to 12%
Consolidated revenue growth target (full year, gross basis)~18%
BTS revenue contribution26% of total revenue, vs 30% in FY24
BTS full-year revenue contribution target~30%
Subsidiary EBITDA margin3%, improved from -0.7% in Q1 FY24
Order book~₹1,600 cr, with 13-15 months average execution period
Order book mix (ER&D / EMS / BTS)~32% / ~42% / ~30%
Net debt (consolidated)₹190 cr, expected to reduce to ~₹180 cr by Sep and ~₹170 cr by year-end
Working capital increase over March levels₹20-25 cr
Top 5 customer revenue concentration~50% of overall revenue